Outpatient management of acute myeloid leukemia after intensive consolidation chemotherapy is feasible and reduces treatment costs

Lewin Eisele, Florian Günther, Peter Ebeling, Jens Nabring, Ulrich Dührsen & Jan Dürig
Background: Acute myeloid leukemia (AML) is an aggressive disease which is rapidly fatal without specific therapy. Intensive consolidation chemotherapy is followed by profound bone marrow aplasia during which patients have been traditionally hospitalized until blood count recovery. We assessed the feasibility[for full text, please go to the a.m. URL]